You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中達集團控股(00139.HK)擬收購廣東友倍親51%股權
格隆匯 02-21 23:02

格隆匯2月21日丨中達集團控股(00139.HK)公吿,公司間接全資子公司深圳中達企業諮詢有限公司於2022年2月21日與廣東省友倍親醫藥科技有限公司股東深圳友倍親醫療投資有限公司簽署股權轉讓協議,約定由深圳中達以人民幣1元收購股東深圳友倍親持有的廣東省友倍親51%的股權共人民幣255萬元出資額。

本次股權轉讓完成後,集團將持有廣東省友倍親51%的股權,廣東省友倍親成為集團的非全資附屬公司。

截至公吿日期,公司就廣東省友倍親股權變更事項正在辦理必要的變更登記手續。

廣東省友倍親未來將與集團共同合作,致力打造一家從事綜合門診、中醫診所、中藥膏方研發、私護凝膠生產、醫療管理培訓的綜合型醫藥公司。希望透過線上、線下一體服務的新模式,依託最新的信息技術及數據分析,重構醫療服務的交付模式,提供診後在線隨診、線上問診和藥物配送、視頻急診、健康管理及慢病管理等線上線下融通的醫療服務。現時普通診所依賴專家醫生的專業技術診斷病情,廣東省友倍親將劃分多類別病例,致力去醫生化,建立中醫診所運營標準管理,扶持每家旗下中醫診所。聯營店將與現有中醫診所合併,與美容院,養生會所合作,低門檻加盟,快速發展同時擁有原有客户基數,最終達到雙方共贏。

通過收購廣東省友倍親股權,集團一直積極尋求多元化其收益來源,公司董事認為該收購與公司長遠發展目標一致,同時符合公司及其股東整體利益。新冠肺炎疫情全球傳播進入第三年,變異毒株接二連三出現,大規模疫苗接種持續推廣而疫情仍不斷反覆,感染病例及死亡病例持續增多。集團希望投資中醫醫療行業,提升大眾健康意識,回饋社會,併為股東創造合理投資價值,打造中醫行業新品質,新標杆。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account